7-Hydroxy.co

Independent reference · Not affiliated with any 7-OH brand

7-Hydroxymitragynine: the full picture.

For some people, 7-OH has been genuinely life-changing — meaningful pain relief, a bridge off prescription opioids, an improvement in quality of life that nothing else provided. For regulators, the same compound raises serious questions about dependence, uncontrolled dosing, and a consumer market that has outpaced the science. Both of those things are true. This site exists to document all of it — the benefits, the risks, and the evolving legal landscape — grounded in primary sources, not marketing or advocacy.

The legal picture is moving fast: 10 states have banned 7-OH, 12 regulate it under Kratom Consumer Protection Acts, and the FDA has recommended Schedule I placement — but the DEA has not acted. We track all 50 states and update when the law changes.

Latest

Minnesotaregulated2026-05-12Nebraskaregulated2026-05-12Tennesseerestricted2026-05-12
5,000×

The concentration difference between the 7-OH that occurs naturally in a kratom leaf (<0.02% by weight) and the semi-synthetic 7-OH in a commercial tablet (up to 98% purity). That gap is what makes concentrated products effective for pain relief at low milligram doses — and it’s also the distinction driving every state-level regulatory debate. Understanding it is the starting point for everything else on this site. Our full guide covers the pharmacology, the market, and the regulatory picture.

Legal status, by state

All 50 states
Banned
10
Restricted
2
Regulated
12
Legal
25

States with restrictions

12 listed

Keep reading

28 cited sources · 50 states tracked · No brand affiliationsEditorial policyReferencesAbout